Condiciones de salud que hierro puede ayudar a apoyar.
Iron is the cornerstone treatment for iron-deficiency anemia (IDA), the world's most common nutritional disorder. Oral iron supplementation (100–200 mg elemental iron/day) corrects hemoglobin deficits and replenishes stores. The American Gastroenterological Association recommends it as first-line therapy; hemoglobin typically rises ~2 g/dL within 4–8 weeks.
Iron is essential for oxygen transport via hemoglobin and myoglobin, and iron-deficiency anemia directly impairs aerobic exercise capacity. A systematic review found iron has among the strongest quality evidence for mineral supplementation in athletic performance. IV and oral iron supplementation in iron-deficient athletes improves aerobic capacity and reduces fatigue.
Iron is a cofactor for tyrosine hydroxylase, the rate-limiting enzyme in dopamine and norepinephrine synthesis, both central to ADHD pathophysiology. Children with ADHD consistently show lower serum ferritin levels than controls in meta-analyses, and a pilot RCT in iron-deficient children with ADHD found significant symptom improvement with ferrous sulfate supplementation.
Iron in breast milk is naturally low (~0.35 mg/L), and exclusive breastfeeding may not meet the growing iron requirements of infants, particularly low-birth-weight and preterm babies. The American Academy of Pediatrics advises exclusively breastfed full-term infants start 1 mg/kg/day of iron from four months of age. For lactating mothers, the RDA drops to 9 mg/day (versus 27 mg/day in pregnancy) because menstrual losses cease and recycled maternal red-cell iron partially compensates. Universal iron supplementation of healthy lactating mothers is generally not considered necessary.
Iron deficiency is documented as a risk factor for recurrent aphthous stomatitis (RAS), with hematinic (iron, folic acid, vitamin B12) deficiencies occurring twice as often in RAS patients as in the general population per StatPearls (NCBI Bookshelf). Correcting iron deficiency through supplementation has been associated with reduction in canker sore frequency. Iron is routinely prescribed alongside other hematinics (B12, folate, zinc) for RAS patients with documented deficiency.
Iron deficiency anemia is the most common extra-intestinal manifestation of celiac disease, arising from malabsorption in the damaged duodenum and proximal jejunum. The ACG 2013 guidelines list iron as among the first micronutrients to screen and supplement at diagnosis. Iron deficiency usually resolves with strict GFD, but supplementation is warranted when deficiency persists.
Iron is essential for hemoglobin synthesis, oxygen transport, and cognitive development in children. NIH ODS-funded label analysis found iron in the 13 core nutrients at or above RDA in most children's MVMs. Children under age 3 and adolescent girls are at particularly high risk of deficiency, making iron a key ingredient in pediatric formulas.
Iron deficiency is directly linked to pediatric sleep-wake disorders including restless legs syndrome (RLS), periodic limb movement disorder (PLMD), and restless sleep disorder. Clinical evidence from pediatric sleep clinics demonstrates iron supplementation improves sleep in iron-deficient children with these conditions, with 73% of children in one institutional study showing improvement in at least one sleep symptom.
Iron deficiency is the most common nutritional deficiency worldwide and a primary, well-established cause of fatigue and low energy. Even without frank anemia, iron deficiency (low ferritin) causes fatigue. Iron repletion in deficient individuals consistently and significantly reduces fatigue. The 2020 Tardy et al. review and NIH ODS confirm iron's central role in oxygen transport and energy metabolism.
Iron status has a dual, complex relationship with cognitive aging: both deficiency (impairing oxygen transport, myelination, and neurotransmitter synthesis) and excessive brain iron accumulation (promoting oxidative stress and interaction with amyloid and tau pathology) are associated with cognitive decline. MRI-based meta-analyses have found elevated iron in the basal ganglia of Alzheimer's disease patients is negatively associated with cognitive performance. In older adults, adequate but not excessive dietary iron intake correlates with better cognitive test performance.
Iron deficiency and iron deficiency anemia are among the most common complications of Crohn's disease, caused by chronic intestinal bleeding, malabsorption, and reduced intake. Iron supplementation (oral or intravenous) is a standard, universally recommended nutritional intervention in CD, endorsed by the Crohn's & Colitis Foundation and all major gastroenterology authorities.
Iron is a central component of hemoglobin, myoglobin, and cytochromes in the electron transport chain, making it essential for oxygen delivery and cellular ATP production. Iron deficiency anemia is one of the most common causes of fatigue worldwide. Supplementation corrects iron-deficiency fatigue and is supported by extensive clinical evidence.
Iron deficiency is linked to ovulatory infertility. A long-term study of more than 18,000 women (Nurses' Health Study) found supplemental iron intake was associated with decreased risk of ovulatory infertility. Deficiency impairs ovarian oxygen delivery, disrupting ovulation. Supplementation benefits women with confirmed deficiency.
Children with ADHD have significantly lower serum ferritin levels than controls (meta-analysis of 17 studies, Hedges' g = -0.246). Iron deficiency impairs dopaminergic neurotransmission contributing to inattention and cognitive deficits. A double-blind RCT found iron supplementation improved ADHD symptoms in iron-deficient children on methylphenidate.
Iron deficiency, even without frank anemia, is associated with impaired attention and concentration in children, adolescents, and adult women. Multiple RCTs and a systematic review and meta-analysis (14 RCTs) found iron supplementation improved attention and concentration with a standardized mean difference of 0.59 (95% CI 0.29–0.90) irrespective of baseline anemia status. The mechanism involves iron's role as a cofactor in dopamine synthesis and receptor expression, a neurotransmitter central to attentional regulation.
Iron deficiency is a well-established modifiable risk factor for hair loss, including telogen effluvium, androgenetic alopecia, and alopecia areata. Iron carries oxygen to hair follicle cells; deficiency impairs the rapidly dividing follicular matrix. Correcting iron deficiency through supplementation in documented deficient patients has shown benefit in hair loss outcomes across multiple studies.
Iron deficiency is one of the best-established nutritional causes of hair loss, particularly telogen effluvium and diffuse alopecia in women. Low ferritin restricts oxygen delivery to the hair bulb, impairing follicle activity. Multiple systematic reviews confirm iron and ferritin deficiency are strongly associated with non-scarring alopecia, and clinical guidelines recommend supplementation in documented deficiency.
Iron deficiency anemia (IDA) and even iron deficiency without anemia (IDWA) are associated with significantly increased prevalence and severity of chronic headaches, including migraine and tension-type headache, particularly in women. A 2025 systematic review and meta-analysis quantified this bidirectional relationship, and iron supplementation has been shown in multiple studies to reduce headache frequency and intensity in iron-deficient patients. Proposed mechanisms include disruption of dopaminergic pain modulation and estrogen-driven fluctuations in iron metabolism.
Iron is essential for hemoglobin synthesis, oxygen transport, and brain development in children. Iron deficiency is the most common nutrient deficiency in the world and is associated with impaired physical growth, anemia, and delayed cognitive and motor development. The WHO, CDC, and IOM all identify iron as a critical nutrient for healthy growth and development in infants, children, and adolescents.
Iron deficiency and iron-deficiency anemia both result from and can worsen heavy menstrual bleeding, creating a bidirectional cycle. Iron deficiency may weaken uterine muscle contractility, impairing hemostasis. A prospective Finnish study (Peuranpää et al., published in Acta Obstet Gynecol Scand 2014) found 27% of women with heavy periods were anemic and 60% severely iron-deficient, and iron supplementation is recommended to improve quality of life and potentially reduce subsequent bleeding.
Iron is an essential cofactor for thyroperoxidase (TPO), the enzyme that catalyzes iodine organification required for thyroid hormone synthesis; iron deficiency impairs this reaction and is common in hypothyroid patients. Studies confirm higher prevalence of iron deficiency in subclinical hypothyroidism. Correction of iron deficiency has been shown to restore thyroid hormone production.
Iron deficiency anemia (IDA) is the most common systemic complication of IBD, arising from chronic intestinal blood loss, malabsorption, reduced dietary intake, and inflammation-driven hepcidin upregulation. European Crohn's and Colitis Organisation (ECCO) guidelines mandate screening and treatment of IDA in IBD patients. Intravenous iron formulations—particularly ferric carboxymaltose and iron sucrose—are preferred in active disease because oral iron has limited absorption and may exacerbate intestinal inflammation.
Iron is the primary, evidence-based treatment for iron-deficiency fatigue. Multiple RCTs and a meta-analysis of six trials found iron supplementation reduced fatigue by more than 60% in premenopausal women with non-anemic iron deficiency. The effect occurs above and beyond placebo even before frank anemia develops.
Iron deficiency negatively affects learning, scholastic achievement, and mental processing speed through disruption of myelination, dopaminergic signaling, and hippocampal neurometabolism. Clinical studies and meta-analyses demonstrate that iron supplementation can improve cognitive development, learning-related test scores, and processing speed, especially in iron-deficient children and women of reproductive age. Effects appear most robust in the presence of confirmed iron deficiency.
Iron is essential for oxygen transport and mitochondrial energy production. Iron deficiency is among the most common causes of fatigue and impaired mental alertness globally, and supplementation in deficient individuals reliably restores cognitive function and energy.
Iron deficiency is a recognized cause of brittle nails, koilonychia (spoon nails), and impaired nail growth due to reduced oxygen delivery to the nail matrix. Multiple clinical reviews document that iron supplementation with vitamin C can improve nail fragility when ferritin is below 10 ng/mL. This is supported by PMC 11961095, PMC 10987172, and PMC 6994568.
Iron is essential for hemoglobin and myoglobin synthesis, oxygen transport, and mitochondrial electron transport, all of which are fundamental to physical endurance. Iron deficiency, even without anemia, impairs aerobic performance and endurance capacity. Correction of iron deficiency in athletes improves VO2max and endurance performance, and iron is recognized by the IOC and leading sport nutrition bodies as a critical nutrient for endurance athletes.
Iron is the most common nutritional deficiency among children globally and is particularly elevated in picky eaters who avoid red meat and animal proteins. Iron deficiency impairs oxygen delivery, cognitive function, and emotional regulation. A 6-month RCT of oral nutritional supplementation in picky eating children documented significant improvement in iron intake inadequacy.
Iron is essential for immune cell proliferation and function, oxygen transport via hemoglobin, and energy metabolism—all impaired in post-illness anemia and recovery states. Iron deficiency anemia is a common consequence of illness requiring targeted supplementation as part of convalescence protocols.
Iron deficiency—including functional deficiency from post-viral inflammation-driven hepcidin elevation—is common in long COVID and contributes to fatigue and reduced exercise capacity. Clinical data show iron-deficiency anemia is prevalent in post-COVID patients and that iron supplementation or IV iron therapy significantly improves exercise tolerance and fatigue.
The WHO and NIH both formally recommend oral iron supplementation for 6–12 weeks postpartum to reduce the risk of anaemia resulting from childbirth blood loss. A 2023 PMC trial in postpartum women with iron-deficiency anaemia showed a mean haemoglobin rise of +3.6 g/dL at day 60 and 81% anaemia correction. Iron is consistently listed by obstetric guidelines as one of the most critical postnatal nutrients.
Iron is a universally recommended prenatal supplement: requirements nearly double during pregnancy to support expanded blood volume, placental development, and fetal iron stores. RCTs confirm iron supplementation prevents iron-deficiency anemia, the most common cause of anemia in pregnancy, which is linked to preterm birth, low birthweight, and impaired infant cognitive development. WHO, ACOG, and NIH ODS all recommend routine iron supplementation during pregnancy.
Iron deficiency is one of the most established secondary causes of RLS. Low serum ferritin is strongly associated with increased RLS prevalence and severity, and oral iron supplementation significantly improves symptoms in deficient patients. International guidelines (IRLSSG) recommend oral iron therapy when serum ferritin is below 75 µg/L.
Iron is a critical cofactor for thyroid peroxidase (TPO), the heme-containing enzyme that catalyzes the iodination of tyrosine residues to form thyroid hormones. Iron deficiency reduces TPO activity, impairs T4-to-T3 conversion, and raises TSH. Clinical trials show concurrent iron and iodine supplementation in iron-deficient goitrous children reduces goiter prevalence more than iodine alone.
Iron is an essential micromineral required for collagen synthesis, oxygen transport to wound sites, and immune cell function. Iron deficiency impairs wound healing by reducing hydroxylation of proline and lysine in collagen formation and impairing neutrophil killing capacity.
Volver